Medtronic PLC Files 8-K: Director Changes and Officer Compensation
Ticker: MDT · Form: 8-K · Filed: Jan 21, 2025 · CIK: 1613103
| Field | Detail |
|---|---|
| Company | Medtronic PLC (MDT) |
| Form Type | 8-K |
| Filed Date | Jan 21, 2025 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001, $850,000, $2 million, $1 million, $600,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, officer-compensation, board-changes
Related Tickers: MDT
TL;DR
Medtronic's board is shuffling, new director elected, exec pay details filed.
AI Summary
On January 17, 2025, Medtronic plc filed an 8-K report detailing the departure of a director and the election of a new director. The filing also disclosed compensatory arrangements for certain officers. Specific details regarding the individuals involved or the financial terms of the compensatory arrangements were not provided in this excerpt.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance matters like director changes and compensation disclosures, which typically carry low immediate risk.
Key Players & Entities
- Medtronic plc (company) — Filer of the 8-K report
- 2025-01-17 (date) — Date of report
FAQ
Who is the departing director and who is the newly elected director?
The filing does not specify the names of the departing or newly elected directors.
What are the details of the compensatory arrangements for certain officers?
The filing indicates that compensatory arrangements for certain officers are disclosed, but the specific details are not provided in this excerpt.
What is the effective date of the changes reported in the 8-K?
The effective date of the changes reported in the 8-K is January 17, 2025.
What specific items are covered under the 'ITEM INFORMATION' section of this filing?
The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers, as well as financial statements and exhibits.
What is Medtronic's fiscal year end?
Medtronic's fiscal year end is April 25 (0425).
Filing Stats: 1,602 words · 6 min read · ~5 pages · Grade level 10.5 · Accepted 2025-01-21 06:51:55
Key Financial Figures
- $0.0001 — registered Ordinary shares, par value $0.0001 per share MDT New York Stock Exchange
- $850,000 — on's initial annual base salary will be $850,000 and he will participate in the Medtroni
- $2 million — Date, with an aggregate target value of $2 million for fiscal year 2025, consisting of: (i
- $1 million — fiscal year 2025, consisting of: (i) a $1 million target performance share unit (PSU) awa
- $600,000 — ith a targeted grant date fair value of $600,000, vesting in 25% increments beginning on
- $400,000 — ard with a targeted grant date value of $400,000, vesting 100% on the third anniversary
- $3 million — t his prior employer, he will receive a $3 million cash bonus, payable in three equal inst
- $2.5 million — ire RSU will have a grant date value of $2.5 million with the number of shares to be calcula
- $24,000 — on and commuter benefits, and an annual $24,000 allowance relating to automobile use, f
- $1,000,000 — y 21, 2025 grant date, in the amount of $1,000,000 to recognize his leadership and contrib
Filing Documents
- mdt-20250117.htm (8-K) — 72KB
- exhibit991-pressreleasedat.htm (EX-99.1) — 11KB
- image_0.jpg (GRAPHIC) — 147KB
- 0001613103-25-000005.txt ( ) — 580KB
- mdt-20250117.xsd (EX-101.SCH) — 7KB
- mdt-20250117_def.xml (EX-101.DEF) — 25KB
- mdt-20250117_lab.xml (EX-101.LAB) — 51KB
- mdt-20250117_pre.xml (EX-101.PRE) — 27KB
- mdt-20250117_htm.xml (XML) — 18KB
01. Exhibits
Item 9.01. Exhibits. (d) List of Exhibits Exhibit Number Description 99.1 Press release of Medtronic plc regarding CFO appointment, dated January 21, 2025. 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Medtronic plc By /s/ Ivan K. Fong Date: January 21, 2025 Ivan K. Fong Executive Vice President, General Counsel and Secretary EXHIBIT INDEX Exhibit Number Description 99.1 Press release of Medtronic plc regarding CFO appointment, dated January 21, 2025. 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).